Quote | Immunotech Labs Inc New (OTCMKTS:IMMB)
Last: | $0.0001 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0001 |
High: | $0 |
Low: | $0 |
Volume: | 25 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Immunotech Labs Inc New (OTCMKTS:IMMB)
The company recently merged with BioClonetics and plans to develop treatments for HIV and COVID-19. However, there are no revenues and its Bulgarian partner denies that Enzolytics has a stake in it. Enzolytics has a valuation of $982.1 million but I don’t think the business...
Enzolytics, Inc. owns licensing rights of the Irreversible Pepsin Fraction peptide molecule for the treatment of HIV/AIDS. The company's treatment appears to be different from other treatments. Enzolytics Inc. claims to be offering a product with zero toxicity issues, minor side effec...
Message Board Posts | Immunotech Labs Inc New (OTCMKTS:IMMB)
Subject | By | Source | When |
---|---|---|---|
Language in both are consistent. | NanoEE | investorshub | 05/17/2022 4:35:04 PM |
I'm looking at it right now, it didn't | GawdyPanther | investorshub | 05/13/2022 3:31:31 PM |
I posted this on the $ENZC board, but | NanoEE | investorshub | 05/13/2022 4:14:05 AM |
Short answer, maybe. 50/50 chance. | NanoEE | investorshub | 04/22/2022 1:30:58 PM |
Anyone know the chances of us getting our | Cass | investorshub | 04/21/2022 9:46:55 PM |